Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
Small cell carcinoma of the prostate or SCCP is a rare, aggressive, and treatment-refractory form of prostate cancer. No good form of treatment is yet known for this disease, and median survival from initial diagnosis is less than 2 years.
Filed under: Management, Treatment, Uncategorized | Tagged: carcinoma, cisplatin, cisplatinum, irinotecan, small cell | 1 Comment »
Intraductal carcinoma of the prostate is occasionally (but rarely) diagnosed on prostate biopsy and is more commonly evident in radical prostatectomy specimens. Basically, this is a type of prostate cancer in which malignant epithelial cells fill large acini and prostatic ducts, and has other specific pathological features.
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: biopsy, carcinoma, intraductal, ouctome | 4 Comments »
A paper from an Australian pathology group has suggested that, “Any proportion of ductal adenocarcinoma in radical prostatectomy specimens predicts extraprostatic extension.”
Filed under: Diagnosis, Management, Risk | Tagged: carcinoma, ductal, pathology, risk | Leave a Comment »
In today’s news there are reports on: Initial diagnosis of intraductal carcinoma of the prostate An aborted trial of HIFU using the Ablatherm device Late rectal complications after prostate brachytherapy
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: Ablatherm, brachytherapy, carcinoma, complications, HIFU, high-intensity focused ultrasound, intraductal, rectal | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site